REGISTERED
on 02 Aug 2022
Last Applicant/ Owned by
One Amgen Center Drive
Thousand Oaks
CA
913201799
Serial Number
88182290 filed on 05th Nov 2018
Registration Number
6809212 registered on 02th Aug 2022
Correspondent Address
Elsa D. Lemoine
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
RIABNI
Pharmaceutical preparations for treatment of inflammatory and auto-immune diseases and disorders; pharmaceutical preparations for treatment of arthritis; pharmaceutical preparations for treatment of diseases and disorders of the immune system and joints; pharmaceutical preparations for treatment of non-Hodgkin's lymphoma (NHL), chronic lymphocytic leukemia (CLL), rheumatoid arthritis (RA), granulo Read More
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical preparations for treatment of inflammatory and auto-immune diseases and disorders; pharmaceutical preparations for treatment of arthritis; pharmaceutical preparations for treatment of diseases and disorders of the immune system and joints; pharmaceutical preparations for treatment of non-Hodgkin's lymphoma (NHL), chronic lymphocytic leukemia (CLL), rheumatoid arthritis (RA), granulomatosis with polyangiitis (GPA), and microscopic polyangiitis (MPA)
First Use Date in General
04th Jan 2021
First Use Date in Commerce
04th Jan 2021
Mark Details
Serial Number
No 88182290
Mark Type
No Service/Collective Mark
Attorney Docket Number
No TM-1826-US-1
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 02th Aug 2022 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 02th Aug 2022 | REGISTERED-PRINCIPAL REGISTER |
| 25th Jun 2022 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 24th Jun 2022 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 21st Jun 2022 | STATEMENT OF USE PROCESSING COMPLETE |
| 16th Jun 2022 | USE AMENDMENT FILED |
| 16th Jun 2022 | TEAS STATEMENT OF USE RECEIVED |
| 03rd May 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 02th May 2022 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 02th May 2022 | SOU EXTENSION 5 GRANTED |